treatment of COVID-19 whit vitamin A
Phase 3
- Conditions
- covid-19.Use this code when COVID-19 has been confirmed by laboratory testing irrespective of severity of clinical signs or symptoms. Use additional code, if desired, to identify pneumonia or other manifestations.U07.1
- Registration Number
- IRCT20200314046774N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 94
Inclusion Criteria
All adult patients were hospitalized with covid_19 who were hospitalized for at least the first three days
Exclusion Criteria
Pregnant women
who with high cerebrospinal fluid pressure
People with malnutrition (celiac disease, short bowel syndrome, chronic pancreatitis, and impaired fat and anti-obesity and bariatric surgery)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of O2 saturation. Timepoint: 1-3-5-7-10-14. Method of measurement: PCR, CT scan and clinical symptoms.;Clinical symptoms. Timepoint: 1-3-5-7-10-14. Method of measurement: PCR, CT scan and clinical symptoms.
- Secondary Outcome Measures
Name Time Method